GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Global Health Ltd (BOM:543654) » Definitions » Enterprise Value

Global Health (BOM:543654) Enterprise Value : ₹316,224 Mil (As of Jun. 01, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Global Health Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Global Health's Enterprise Value is ₹316,224 Mil. Global Health's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ₹7,010 Mil. Therefore, Global Health's EV-to-EBIT ratio for today is 45.11.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Global Health's Enterprise Value is ₹316,224 Mil. Global Health's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ₹8,737 Mil. Therefore, Global Health's EV-to-EBITDA ratio for today is 36.19.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Global Health's Enterprise Value is ₹316,224 Mil. Global Health's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ₹32,751 Mil. Therefore, Global Health's EV-to-Revenue ratio for today is 9.66.


Global Health Enterprise Value Historical Data

The historical data trend for Global Health's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Global Health Enterprise Value Chart

Global Health Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
Enterprise Value
- - - 139,222.49 351,344.04

Global Health Quarterly Data
Mar20 Mar21 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 139,222.49 176,962.33 189,877.50 257,340.96 351,344.04

Competitive Comparison of Global Health's Enterprise Value

For the Medical Care Facilities subindustry, Global Health's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Global Health's Enterprise Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Global Health's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Global Health's Enterprise Value falls into.



Global Health Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Global Health's Enterprise Value for the fiscal year that ended in Mar. 2024 is calculated as

Global Health's Enterprise Value for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Global Health  (BOM:543654) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Global Health's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=316224.116/7010.12
=45.11

Global Health's current Enterprise Value is ₹316,224 Mil.
Global Health's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹7,010 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Global Health's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=316224.116/8737.4
=36.19

Global Health's current Enterprise Value is ₹316,224 Mil.
Global Health's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹8,737 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Global Health's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=316224.116/32751.11
=9.66

Global Health's current Enterprise Value is ₹316,224 Mil.
Global Health's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹32,751 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Global Health Enterprise Value Related Terms

Thank you for viewing the detailed overview of Global Health's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Global Health (BOM:543654) Business Description

Traded in Other Exchanges
Address
E - 18, Medanta - The Medicity, Defence Colony, New Delhi, IND, 110024
Global Health Ltd operates as a private multi-specialty tertiary care provider operating in the North and East regions of India, with key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology. Under the Medanta brand, it has a network of hospitals in operation (Gurugram, Indore, Ranchi, and Lucknow), a hospital that is under construction with an operational outpatient facility (Patna), and a hospital (Noida) planned for development. The Group operates Healthcare services as a single business segment in India, constituting a single geographical segment.

Global Health (BOM:543654) Headlines

No Headlines